300497 富祥药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-2.547-7.774-5.0881.65914.200
总资产报酬率 ROA (%)-1.311-4.065-2.9051.1199.615
投入资产回报率 ROIC (%)-1.424-4.448-3.2371.2568.694

边际利润分析
销售毛利率 (%)9.91410.62718.03630.49840.438
营业利润率 (%)-6.432-14.251-8.1323.98825.921
息税前利润/营业总收入 (%)-4.144-12.878-8.6764.77927.293
净利润/营业总收入 (%)-7.085-13.870-9.9672.76621.580

收益指标分析
经营活动净收益/利润总额(%)159.34170.590-16.215298.61194.785
价值变动净收益/利润总额(%)1.7126.64958.112-239.689-4.108
营业外收支净额/利润总额(%)0.5371.6226.133-3.515-2.160

偿债能力分析
流动比率 (X)1.1591.4601.7711.7002.674
速动比率 (X)0.8641.1221.3311.3942.349
资产负债率 (%)48.65348.73046.84337.77324.667
带息债务/全部投入资本 (%)42.48542.67539.99529.444--
股东权益/带息债务 (%)131.713130.932146.304235.205536.170
股东权益/负债合计 (%)105.642105.813113.123162.983301.359
利息保障倍数 (X)-1.784-8.008673.8665.15614.219

营运能力分析
应收账款周转天数 (天)79.10963.29457.39454.7920.000
存货周转天数 (天)132.365123.665129.296127.5660.000